Invests in royalties for medicines.
Jun 2026Revenue $291M/yrExpenses $196M/yr
No trend
Figures by year
Is Ligand Pharmaceuticals profitable?
Yes. In the 12 months to Jun 2026, revenue was $291M and expenses $196M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $268M | $227M | $41.0M |
| Dec 2024 | $167M | $190M | −$22.6M |
| Dec 2023 | $131M | $119M | $11.9M |
| Dec 2022 | $196M | $193M | $3.04M |
| Dec 2021 | $242M | $138M | $104M |
| Dec 2020 | $164M | $126M | $37.5M |
| Dec 2019 | $120M | −$687M | $807M |
| Dec 2018 | $251M | $87.7M | $164M |
| Dec 2017 | $141M | $73.0M | $68.1M |
| Dec 2016 | $109M | $65.1M | $43.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.